Services & Products

CRDMO for API

Oligos for IVD

Powering the Advancement of RNAi Therapeutics and Genomic Diagnostics

Founded in 2011, BiOligo is a specialized supplier and CRDMO partner for the nucleic acid therapeutics and in vitro diagnostics (IVD) industries.

For nucleic acid therapeutics, BiOligo supports OD- to kilogram-scale production with capabilities in high purity, low endotoxin, process consistency, and scalable manufacturing, serving pharmaceutical and biotechnology companies across the drug development lifecycle.

For IVD, BiOligo provides primers and probes, enzymes, and NGS reagents, supported by high-purity manufacturing and our Sterile Oligo Synthesis Management Platform for controlled microbial background and consistent quality, supporting diagnostic companies and laboratories across the development and commercialization of molecular diagnostic applications.

BiOligo Global Network
Our Impact
OD to kg+ Production Capacity
200+ Modification
50+ Patents
3,000+ Global Customers

What do our customers say?

TESTIMONIALS

·

Chief Operating Officer

Molecular Diagnostics Solution Company, UK

Having our orders delivered in exact and consistent final yields makes batch planning so much easier! This totally avoids the trouble of order delays or re-orders for us, especially when our products require hundreds of oligos in use.

Drug Development Scientist

Oligonucleotide Therapeutics Company, USA

We ordered 15 grams of siRNA from BiOligo, and the endotoxin level came back below 0.01 EU/mg. That made things a lot easier in our animal studies, especially when we were trying to make sure endotoxin wasn’t affecting the results. It was a big relief, honestly. Knowing the siRNA was this clean gave us one less thing to worry about when evaluating our candidates.

How can we help you?

It's our pleasure to support you.